Bharat Immunologicals (India) Risk Analysis

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 24.90  0.35  1.43%

Macroaxis considers Bharat Immunologicals not very volatile given 2 months investment horizon. Bharat Immunologicals secures Sharpe Ratio (or Efficiency) of 0.0728 which signifies that Bharat Immunologicals had 0.0728% of return per unit of standard deviation over the last 2 months. Our philosophy in foreseeing volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Bharat Immunologicals Biologicals Corp Ltd which you can use to evaluate future volatility of the firm. Please makes use of Bharat Immunologicals Mean Deviation of 1.52 and Risk Adjusted Performance of 0.1304 to double-check if our risk estimates are consistent with your expectations.
 Time Horizon     30 Days    Login   to change

Bharat Immunologicals Market Sensitivity

As returns on market increase, Bharat Immunologicals returns are expected to increase less than the market. However during bear market, the loss on holding Bharat Immunologicals will be expected to be smaller as well.
2 Months Beta |Analyze Bharat Immunologicals Demand Trend
Check current 30 days Bharat Immunologicals correlation with market (DOW)
β = 0.1934
Bharat Immunologicals Small BetaBharat Immunologicals Beta Legend

Bharat Immunologicals Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of thirty-nine. Bharat Immunologicals Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input. View also all equity analysis or get more info about average price price transform indicator.

Projected Return Density Against Market

Assuming 30 trading days horizon, Bharat Immunologicals has beta of 0.1934 . This suggests as returns on market go up, Bharat Immunologicals average returns are expected to increase less than the benchmark. However during bear market, the loss on holding Bharat Immunologicals Biologicals Corp Ltd will be expected to be much smaller as well. Moreover, Bharat Immunologicals Biologicals Corp Ltd has an alpha of 0.1685 implying that it can potentially generate 0.1685% excess return over DOW after adjusting for the inherited market risk (beta).
 Predicted Return Density 
      Returns 
Assuming 30 trading days horizon, the coefficient of variation of Bharat Immunologicals is 1374.19. The daily returns are destributed with a variance of 12.64 and standard deviation of 3.55. The mean deviation of Bharat Immunologicals Biologicals Corp Ltd is currently at 2.05. For similar time horizon, the selected benchmark (DOW) has volatility of 1.69
α
Alpha over DOW
=0.17
β
Beta against DOW=0.19
σ
Overall volatility
=3.55
Ir
Information ratio =0.0856

Actual Return Volatility

Bharat Immunologicals Biologicals Corp Ltd accepts 3.5549% volatility on return distribution over the 30 days horizon. DOW inherits 1.4224% risk (volatility on return distribution) over the 30 days horizon.
 Performance (%) 
      Timeline 

Market Risk Breakdown

Bharat Immunologicals Volatility Factors

60 Days Market Risk

Not very volatile

Chance of Distress in 24 months

Almost imposible

60 Days Economic Sensitivity

Barely shadows market

Investment Outlook

Bharat Immunologicals Investment Opportunity
Bharat Immunologicals Biologicals Corp Ltd has a volatility of 3.55 and is 2.5 times more volatile than DOW. 32% of all equities and portfolios are less risky than Bharat Immunologicals. Compared to the overall equity markets, volatility of historical daily returns of Bharat Immunologicals Biologicals Corp Ltd is lower than 32 (%) of all global equities and portfolios over the last 30 days. Use Bharat Immunologicals Biologicals Corp Ltd to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of Bharat Immunologicals to be traded at 27.39 in 30 days. As returns on market increase, Bharat Immunologicals returns are expected to increase less than the market. However during bear market, the loss on holding Bharat Immunologicals will be expected to be smaller as well.

Bharat Immunologicals correlation with market

Average diversification
Overlapping area represents the amount of risk that can be diversified away by holding Bharat Immunologicals Biologic and equity matching DJI index in the same portfolio.

Volatility Indicators

Bharat Immunologicals Current Risk Indicators
Check also Trending Equities. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.